Bioshares top 6 2017, page-32

BIOSHARES report not worth the Paper it's written on..
Gives INNATE a Class A...(Innate only one drug)

Gives ANP a class C.
(ANP 2 drugs )

Boishares is a Joke...Hmmm wonder Why IIL got a cl
Ass A..???


Speculative Buy – Class A
These stocks will have more than one technology, product or investment in development, with perhaps those same technologies offering multiple opportunities. These features, coupled to the presence of alliances, partnerships and scientific advisory boards, indicate the stock is relative less risky than other biotech stocks. Speculative Buy – Class B
These stocks may have more than one product or opportunity, and may even be close to market. However, they are likely to be lacking in several key areas. For example, their cash position is weak, or management or board may need strengthening.
Speculative Buy – Class C
These stocks generally have one product in development and lack many external validation features.
Speculative Hold – Class A or B or C
Sell